Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Physical multimorbidity and subjective cognitive complaints among adults in the United Kingdom: a cross-sectional community-based study

dc.contributor.authorJacob, Louis
dc.contributor.authorHaro Abad, Josep Maria
dc.contributor.authorKoyanagi, Ai
dc.date.accessioned2021-04-28T09:08:27Z
dc.date.available2021-04-28T09:08:27Z
dc.date.issued2019-08-27
dc.date.updated2021-04-28T09:08:27Z
dc.description.abstractOur goal was to examine the association between physical multimorbidity and subjective cognitive complaints (SCC) using UK nationally representative cross-sectional community-based data, and to quantify the extent to which a broad range of mainly psychological and behavioral factors explain this relationship. Data from the 2007 Adult Psychiatric Morbidity Survey were analyzed [N = 7399 adults, mean (SD) age 46.3 (18.6) years, 48.6% men]. Multimorbidity was defined as ≥2 physical diseases. SCC included two different cognitive constructs: subjective concentration and memory complaints. Multivariable logistic regression and mediation analyses were conducted. Multimorbidity was associated with higher prevalence of subjective concentration (30.7% vs. 17.3%) and memory complaints (42.8% vs. 22.9%) compared to no multimorbidity. In the regression model adjusted for sociodemographics, multimorbidity was associated with subjective concentration (OR = 2.58; 95% CI = 2.25-2.96) and memory complaints (OR = 2.34; 95% CI = 2.08-2.62). Sleep problems, stressful life events and any anxiety disorder explained 21-23%, 20-22% and 14-15% of the multimorbidity-SCC association, respectively. Multimorbidity and SCC are highly co-morbid. The utility of SCC screening in identifying individuals at high risk for future cognitive decline among individuals with multimorbidity should be assessed.
dc.format.extent11 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec697947
dc.identifier.issn2045-2322
dc.identifier.pmid31455875
dc.identifier.urihttps://hdl.handle.net/2445/176801
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-019-48894-8
dc.relation.ispartofScientific Reports, 2019, vol. 9, num. 1, p. 12417
dc.relation.urihttps://doi.org/10.1038/s41598-019-48894-8
dc.rightscc-by (c) Jacob, Louis et al., 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationMorbiditat
dc.subject.classificationCognició
dc.subject.classificationAnsietat
dc.subject.otherMorbidity
dc.subject.otherCognition
dc.subject.otherAnxiety
dc.titlePhysical multimorbidity and subjective cognitive complaints among adults in the United Kingdom: a cross-sectional community-based study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
697947.pdf
Mida:
1.23 MB
Format:
Adobe Portable Document Format